Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,747.50
Bid: 1,747.00
Ask: 1,748.00
Change: -27.50 (-1.55%)
Spread: 1.00 (0.057%)
Open: 1,770.00
High: 1,770.00
Low: 1,746.50
Prev. Close: 1,775.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 1-GSK-linked investigator freed early from China jail - source

Tue, 09th Jun 2015 14:15

(Adds British consulate statement, GSK no comment, context)

By John Ruwitch

SHANGHAI, June 9 (Reuters) - A British corporateinvestigator linked to a bribery scandal in China involvingdrugmaker GlaxoSmithKline PLC is to be released earlyfrom a 2 1/2-year sentence in a Chinese jail, a source close tohis family said on Tuesday.

Peter Humphrey and his American wife, Yu Yingzeng, weresentenced in August last year for illegally obtaining privaterecords of Chinese citizens and selling the information on toclients including GSK.

The source, who declined to be identified, said Humphrey hadbeen informed on Tuesday by a Shanghai court that his sentencewould be reduced by seven months. He had originally beenexpected to be released in January next year.

The case was intertwined with an investigation of GSK inChina which rocked the country's pharmaceutical market and ledto a $489 million fine against the firm last year for payingbribes to doctors to use its drugs.

Humphrey is in a Shanghai hospital undergoing tests and theBritish consulate is processing an emergency passport for him,so he can be deported once he is released from hospital, thesource said.

It was not clear when Humphrey would officially be released.Yu, who was sentenced to two years in jail, will be freed incoming weeks.

"We have been notified by the Chinese authorities that aBritish national detained in China has been released. We areproviding consular assistance to the family," a spokesman forthe British consulate in Shanghai said.

Humphrey and Yu, who ran risk consultancy ChinaWhys, hadbeen asked by GSK to compile a report into the origins of a sexvideo involving its former China head Mark Reilly, which hadbeen sent to senior executives at the British firm along withanonymous emails alleging corruption.

On July 10, 2013, Chinese authorities detained Humphrey andYu. Days later police accused GSK of funnelling up to 3 billionyuan ($482 million) through travel agencies to bribe doctors andofficials in China.

A UK-based spokesman for GSK declined to comment on thereports that the couple are to be freed. Two lawyers who actedfor Humphrey and Yu last year said they were not aware of thedecision.

President Xi Jinping will travel to Britain for a statevisit in October, 10 years after the last such visit by aChinese president. (Additional reporting by Brenda Goh in Shanghai and BenHirschler in London; Writing by Adam Jourdan; Editing by AndrewRoche)

More News
13 Feb 2024 09:32

LONDON BROKER RATINGS: Citi lifts GSK; Shore likes XPS Pensions

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
13 Feb 2024 07:45

LONDON BRIEFING: "Record" Tui quarter; Ultimate Products eyes payouts

(Alliance News) - London's FTSE 100 is to open ever-so-slightly lower on Tuesday, with trade set to be nervy ahead of the afternoon's US inflation data.

Read more
12 Feb 2024 17:11

London close: Stocks finish higher after very quiet Monday

(Sharecast News) - London markets managed modest gains by the close of a subdued trading session on Monday, with no significant corporate or economic catalysts driving movements.

Read more
12 Feb 2024 12:04

LONDON MARKET MIDDAY: FTSE 100 underperforms as European peers rise

(Alliance News) - London's FTSE 100 underwhelmed on Monday, with some of its largest constituents pulling it lower, while indices in Europe were on the up on favourable comments on interest rate cuts by a European Central Bank official.

Read more
12 Feb 2024 08:35

TOP NEWS: GSK's bepirovirsen receives US FDA fast track designation

(Alliance News) - GSK PLC on Monday said that the US health watchdog granted fast track designation for its bepirovirsen treatment for chronic hepatitis B.

Read more
12 Feb 2024 07:50

LONDON BRIEFING: Tritax Big Box, UK Commercial Property agree merger

(Alliance News) - Equities in London are called to open higher on Monday, with inflation readings from the US and UK on the horizon, which could drive equity market sentiment during the remainder of the week.

Read more
12 Feb 2024 07:21

GSK gets FDA fast track for chronic hepatitis B treatment

(Sharecast News) - GSK announced on Monday that bepirovirsen, an investigational antisense oligonucleotide (ASO) aimed at treating chronic hepatitis B (CHB), had been granted fast track designation by the US Food and Drug Administration (FDA).

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
6 Feb 2024 08:51

TOP NEWS: GSK reports positive news on trio of high profile products

(Alliance News) - GSK PLC on Tuesday delivered a triple dose of positive updates on some of its leading products, Arexvy, Shingrix and Blencep.

Read more
6 Feb 2024 07:47

LONDON BRIEFING: BP promises buyback despite drop in profit

(Alliance News) - Stocks in London are called to open higher, ahead of a slew of construction purchasing managers' index readings from the eurozone, the UK and Germany.

Read more
6 Feb 2024 07:23

GSK reports positive myeloma trial results, progresses vaccine applications

(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.

Read more
1 Feb 2024 09:27

TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case

(Alliance News) - GSK PLC on Thursday insisted upon its scientific integrity, after reaching another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
1 Feb 2024 09:11

GSK settles Zantac case in California without admitting liability

(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.

Read more
1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
1 Feb 2024 07:42

LONDON BRIEFING: Shell profit falls; announces USD3.5 billion buyback

(Alliance News) - Stocks in London are set to follow New York into the red, after the US Federal Reserve quashed hopes of a March cut to interest rates and ahead of the Bank of England interest rate decision.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.